BIOFIELD PHARMA PVT. LTD.

What BIOFIELD PHARMA PVT. LTD. does

Biofield Pharma Pvt. Ltd. is an Indian pharmaceutical company headquartered in Panchkula, Haryana, founded approximately in 1999. The company operates a PCD (Propaganda Cum Distribution) franchise model, distributing 950+ branded products through 300+ associates across India on a monopoly-territory basis. It holds 10,000+ product approvals and operates a vertically integrated manufacturing capability through its subsidiary Astonea Labs, which supports both own-brand production and third-party contract manufacturing.

The company's go-to-market combines a domestic franchise distribution network with international export operations spanning six continents: Africa, Asia, Europe, North America, South America, and Oceania. Biofield holds multiple regulatory certifications including ISO 9001:2015, WHO GMP, EU GMP, and USFDA, which serve as prerequisites for regulated export markets. Third-party manufacturing services leveraging its product approval portfolio represent an additional revenue channel beyond branded distribution.

Biofield is a small-scale operator with 26 employees and no disclosed external funding. Its strategy centers on incremental portfolio expansion (15-20 new molecules per month), export channel development through international trade show participation, and capitalizing on regulatory certifications to access regulated markets. The combined franchise-plus-manufacturing-plus-export model creates three distinct revenue streams within a single vertically integrated entity.

Name

BIOFIELD PHARMA PVT. LTD.

Legal name

Biofield Pharma Pvt. Ltd.

Website

https://biofieldpharma.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Biofield Pharma is an Indian pharmaceutical company operating a PCD franchise model with 950+ products distributed through 300+ associates, vertically integrated manufacturing via subsidiary Astonea Labs, and exports spanning six continents under WHO GMP, EU GMP, and USFDA certifications.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Specialty Pharmacy & Biologics Distribution (CRAOAHAD), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

Keywords

• Pharmaceutical manufacturing
• PCD pharma franchise
• Third-party manufacturing
• Generic formulations
• Pharmaceutical exports

Headquarters

HQ city

Panchkula

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. PCD Pharma Franchise Product Sales: Revenue generated from selling 950+ branded pharmaceutical products through a network of monopoly-based franchise distributors across India. Associates receive exclusive distribution rights in their territories and purchase products at wholesale prices for resale.
2. Third-Party Manufacturing Services: Contract manufacturing services for domestic and international pharmaceutical companies. The company offers end-to-end project management including brand name selection, trademark registration, product design, scientific training manuals, and regulatory compliance support. Portfolio of over 10,000 product approvals covering BETA (EU GMP, WHO/GMP), NON-BETA (USFDA, WHO/GMP), and NUTRACEUTICALS (USFDA, WHO/GMP, HALAL, HACCP).
3. Pharmaceutical Export: Export of DCGI-approved formulations and nutraceutical products to markets across Africa, Asia, Europe, North America, South America, and Oceania, supported by COPP procurement, dossier preparation, and international brand registration.
4. Protein Powders and Sachets: Sale of nutritional supplements including protein hydrolysate powders and sachets through PCD franchise model.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Biofield Pharma manufactures and distributes a portfolio of 950+ branded pharmaceutical formulations across multiple therapeutic segments (cardiac, diabetic, anti-infectives, critical care, neuro-psychiatrics, orthopedic, gynaecology, anti-malaria, respiratory, gastro, cancer, AIDS, tuberculosis, etc.) in dosage forms including tablets, capsules, syrups, sachets, ointments, lotions, soft gelatin capsules, dry powder injections, liquid injections, and eye/ear drops. The company operates in-house manufacturing through Astonea Labs, provides PCD pharma franchise distribution, offers third-party/contract manufacturing services, and exports pharmaceutical products internationally. The company is certified to WHO GMP, EU GMP, USFDA, and ISO 9001:2015 standards.

Product overview

Biofield Pharma Pvt Ltd is a pharmaceutical company offering over 950 branded products across multiple therapeutic segments. The portfolio spans tablets, capsules, softgel capsules, syrups/suspensions, ointments, injectables, protein powders, and sachets. Key product lines include General Range, Anti-histamine & Anticold, Anti Bacterial & Anti Infectives, Gastro PPI & Antacids, Multivitamin Multiminerals & Antioxidants, Iron & Calcium Supplements, Pain Management, Ortho Range, Gynae Range, Paediatric Range, Eye/Nasal Drops, Dental Range, Cardiac Diabetic, Derma Range, and Injectables. The company operates through PCD pharma franchise model and offers third-party manufacturing and export services, with products manufactured at WHO/GMP certified facilities. Unique brand names include OSTANU (calcium/Vitamin D3 supplements), IFCOF (cough/respiratory), CETLOC (allergy), AUTOBACT (antibiotics), OZISET (antibiotics), FAIRGEST (gynecology), CLEARCYST (PCOS), and NUTRAFAST (protein supplements). The company exports to markets across Africa, Asia, Europe, North America, South America, and Oceania.

Differentiator

Problem solved

Functional benefit

Brands

• OSTANU: Calcium and vitamin D3 supplement brand including tablets, softgels, sachets, and suspensions
• IFCOF
• AUTOBACT
• CETLOC
• AFTERCOLD
• BACILO-RITE
• COQFINE
• NUTRAFAST

Products and services

• Branded Pharmaceutical Formulations

Quantifiable outcome

• Over 950 branded products in ready stock covering 15+ therapeutic segments
• +4 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Astonea Labs Pvt LtdcoreTechnology or IntegrationAstonea Labs Pvt Ltd is the in-house manufacturing unit of Biofield Pharma, operating a WHO GMP certified and USFDA OTC accredited facility. It produces tablets, capsules, ointments, and syrups for Biofield Pharma's product portfolio. Located at Haripur, Teh. Raipurani, Distt. Panchkula, Haryana, this is a vertically integrated manufacturing partnership providing supply chain control and quality assurance.
• Biorise PharmaceuticalsminorOthersBiorise Pharmaceuticals is listed as an associate company of Biofield Pharma Group, sharing the same brand ecosystem and pharmaceutical distribution network.
• Stelon BiotechminorOthersStelon Biotech is listed as an associate company of Biofield Pharma Group, operating within the same pharmaceutical brand ecosystem.
• Astonea Labs LtdminorOthersAstonea Labs Ltd is listed as an associate company of Biofield Pharma Group alongside Biorise Pharmaceuticals and Stelon Biotech.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Cipla: Largest Indian pharma incumbent offering branded generics, APIs, and complex generics spanning respiratory, cardiology, and anti-infectives. Competes in the same therapy areas where Biofield operates.
• Sun Pharmaceutical Industries: India's largest pharma company by revenue, offering branded generics across essentially all therapeutic categories Biofield operates in, including dermatology, cardiology, and gynae. Represents the upper bound of branded-generic competition.
• Lupin Limited: Major Indian pharma with strong branded generics portfolio across anti-infectives, cardiovascular, and dermatology, plus growing global footprint. Comparable in therapeutic coverage and franchise-like domestic distribution.
• Zydus Lifesciences: Indian pharma major with branded generics, APIs, and biologics across primary care and specialty. USFDA-approved manufacturing and a domestic franchise network comparable to Biofield's structure.

Direct peers

• Mankind Pharma: India's leading PCD pharma franchise and branded generics manufacturer with comparable product breadth across primary care and specialty segments. Operates a similar franchise/distribution-led go-to-market serving Indian pharmacies.
• Aristo Pharmaceuticals: Indian branded generics manufacturer focusing on multi-therapy portfolios (anti-infectives, cardiology, dermatology) with PCD-style distribution across India. Comparable scale and therapeutic breadth to Biofield.
• Alkem Laboratories: Large Indian branded generics manufacturer with significant franchise distribution presence across therapeutic categories aligned with Biofield's portfolio. Comparable in offering generics across multiple specialties with WHO-GMP manufacturing.

Emerging players

• Ridley Lifesciences: Indian PCD pharma franchise player offering generics across gynecology, orthopedics, derma, and general segments. Comparable in franchise-led distribution, product breadth, and export aspirations to Biofield.
• Medibox Pharma: Pure-play PCD pharma franchise distributor offering multi-therapy branded generics to franchise partners across India. Closely comparable GTM motion and product breadth to Biofield at a similar scale.
• Troikaa Pharmaceuticals: Mid-sized Indian pharma offering niche formulations (topical anesthetics, anti-infectives, dermatology) with growing domestic and emerging-market export presence. Comparable in therapeutic focus and PCD-style distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biofield-pharma

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOFIELD PHARMA PVT. LTD.